At A Glance
1
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs.
2
Revenue is primarily driven by Exclusive Product License (100%).
3
No significant events in the past 90 days.
—
Market Cap
—
Revenue
—
Net Income
Employees23
Fundamentals
How The Business Makes Money
Revenue by Segment
Exclusive Product License100%($500.0K)
Activity
What Changed Recently
No significant events in the past 90 days.
Analyst View
Company Profile
CIK0001205922
ISINUS9186403013
CUSIP918640103
Phone585 271 2700
Address1895 Mount Hope Avenue, Rochester, NY, 14620, US
SEC EDGAR